These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 23488726)

  • 1. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.
    Aubin HJ; Luquiens A; Berlin I
    Br J Clin Pharmacol; 2014 Feb; 77(2):324-36. PubMed ID: 23488726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for smoking cessation: present and future.
    Aubin HJ; Karila L; Reynaud M
    Curr Pharm Des; 2011; 17(14):1343-50. PubMed ID: 21524268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
    Rose JE; Behm FM
    Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
    Kotz D; Simpson C; Viechtbauer W; van Schayck OC; West R; Sheikh A
    BMJ Open; 2014 Aug; 4(8):e005281. PubMed ID: 25168037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current and future medical drugs for smoking cessation].
    Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
    Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
    Cinciripini PM; Robinson JD; Karam-Hage M; Minnix JA; Lam C; Versace F; Brown VL; Engelmann JM; Wetter DW
    JAMA Psychiatry; 2013 May; 70(5):522-33. PubMed ID: 23536105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
    Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T
    Addiction; 2014 Sep; 109(9):1414-25. PubMed ID: 24995905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants for smoking cessation.
    Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
    Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
    JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants for smoking cessation.
    Hajizadeh A; Howes S; Theodoulou A; Klemperer E; Hartmann-Boyce J; Livingstone-Banks J; Lindson N
    Cochrane Database Syst Rev; 2023 May; 5(5):CD000031. PubMed ID: 37230961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
    Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE
    Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.
    Le Houezec J; Aubin HJ
    Expert Opin Pharmacother; 2013 Oct; 14(14):1959-67. PubMed ID: 23978314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.